Drug Delivery Products - Industry Market Research, Market Share, Market Size, Sales, Demand Forecast, Market Leaders, Company Profiles, Industry Trends

Demand for drug delivery products in the US will rise 6.1 percent yearly to $251 billion in 2019. Parenteral products will grow the fastest, driven by monoclonal antibodies and polymer-encapsulated medicines. Hormones and central nervous system agents will lead gains by application. Pen injectors and retractable prefillable syringes will pace devices.

This study analyzes the $187 billion US drug delivery system industry. It presents historical demand data (2004, 2009 and 2014) and forecasts (2019 and 2024) by product (e.g., oral, parenteral, inhalation, transdermal, implantable) and application (e.g., central nervous system, hormones, respiratory, anti-infective, cardiovascular, gastrointestinal, nutritional).

The study also considers market environment factors, details industry structure, evaluates company market share, and profiles 30 industry players, including Gilead Sciences, Roche, and Johnson & Johnson.

Purchase Options/View Brochure   

Table of Contents

INTRODUCTION

EXECUTIVE SUMMARY

MARKET ENVIRONMENT

General

Economic Factors

Demographic Patterns

Healthcare Trends

Health Insurance Reforms

Medical Conditions

Acute Conditions

Chronic Conditions

National Health Expenditures

Spending Categories

Funding Sources

Medical Providers

Hospitals

Outpatient Facilities

Physicians

Skilled Nursing Homes

Patient Activity

Hospital Activity

Outpatient Activity

Surgical Procedures

Pharmaceutical Industry Overview

Regulation

Research & Development

Product Demand

Therapeutic Groups

Dosage Formulations

Regulatory Classes

Commercial Status

DRUG DELIVERY PRODUCT OVERVIEW

General

Types of Drug Delivery Products

Historical Market Trends

US Trade

International Markets

ORAL DRUG DELIVERY PRODUCTS

General

Controlled-Release Formulations

Film-Coated Formulations

Diffusion Formulations

Reservoir Formulations

Chewable Tablets

Orally Disintegrating Tablets

Nanoparticulate Formulations

Transmucosal Formulations

PARENTERAL DRUG DELIVERY PRODUCTS

General

Therapeutic Monoclonal Antibodies

Technology

Products

HUMIRA (adalimumab)

REMICADE (infliximab)

RITUXAN (rituximab)

AVASTIN (bevacizumab)

HERCEPTIN (trastuzumab)

LUCENTIS (ranibizumab)

STELARA (ustekinumab)

XOLAIR (omalizumab)

TYSABRI (natalizumab)

Other Monoclonal Antibodies

New Products

Developmental Products

Encapsulated Parenteral Formulations

Polymer-Protected Formulations

PEG-Based Parenteral Therapies

Other Polymer-Protected Parenteral Therapies

Developmental Activities

Liposomes

Technology

Marketed Products

Developmental Activities

Infusion Products

IV Administration Sets

Premixed IV Solutions

Infusion Pumps

Other Infusion Products

Enteral Feeding Supplies

IV Accessories

Parenteral Devices

Prefillable Syringes

Injectors

Cartridge Systems

Hypodermic Syringes

IV Catheters

Other Parenteral Devices

OTHER DRUG DELIVERY PRODUCTS

General

Inhalation Drug Delivery Products

Dry Powder Formulations

Metered Dose Formulations

Transdermal Drug Delivery Products

Transdermal Technologies

Central Nervous System Agents

Hormones & Related Agents

Cardiovascular Agents

Other Transdermal Patches

Implantable Drug Delivery Products

Drug Inserts

Drug-Eluting Stents

Other Implantable Drug Delivery Products

Brachytherapy Products

Implantable Drug Pumps

APPLICATIONS

General

Central Nervous System Agents

Controlled-Release Formulations

Other Oral Drug Delivery Products

Transdermal Formulations

Monoclonal Antibodies & Polymer Encapsulated Therapies

Liposomes

Other Drug Delivery Products

Hormones & Related Agents

Anticancer Monoclonal Antibodies

Encapsulated Polymers

Liposomes

Insulin Pen Injectors

Controlled-Release & Other Oral Drug Delivery Products

Transdermal Hormones & Related Agents

Other Drug Delivery Products

Respiratory Agents

Dry Powder Inhalers

Metered Dose Inhalers

Monoclonal Antibodies

Anti-Infective Agents

Cardiovascular Agents

Controlled-Release Formulations

Monoclonal Antibodies

Drug-Eluting Stents

Transdermal Patches

Gastrointestinal Agents

Nutritional Agents

Other Pharmaceuticals

INDUSTRY STRUCTURE

General

Market Share

Dosage Formulations

Devices

Competitive Strategies

Mergers & Acquisitions

Licensing & Related Agreements

Marketing & Distribution

Manufacturing

Company Profiles

Abbott Laboratories

AbbVie Incorporated

Actavis, see Allergan

Adare Pharmaceuticals Incorporated

Allergan plc

Amgen Incorporated

Animas, see Johnson & Johnson

Aptalis Pharma, see Allergan

Aptalis Pharmaceutical Technologies, see Adare Pharmaceuticals

AptarGroup Incorporated

AstraZeneca plc

Baxter International Incorporated

Becton, Dickinson, and Company

Boehringer Ingelheim GmbH

Braun (B.) Melsungen AG

Bristol-Myers Squibb Company

CareFusion, see Becton, Dickinson

Evonik Industries AG

Forest Laboratories, see Allergan

Genentech, see Roche Holding

Genzyme, see Sanofi

Gerresheimer AG

Gilead Sciences Incorporated

GlaxoSmithKline plc

Hospira, see Pfizer

ImClone Systems, see Lilly (Eli)

Janssen Pharmaceuticals, see Johnson & Johnson

Johnson & Johnson

Lilly (Eli) and Company

MedImmune, see AstraZeneca

Merck & Company Incorporated

Nitto Denko Corporation

Novartis AG

Novo Nordisk A/S

Pfizer Incorporated

Regeneron Pharmaceuticals, see Sanofi

Roche Holding Limited

Sanofi

Teva Pharmaceutical Industries Limited

3M Company

Unilife Corporation

Vetter Pharma International GmbH

West Pharmaceutical Services Incorporated

Additional Companies in the Drug Delivery Product Market

List of Tables

EXECUTIVE SUMMARY

Summary Table

MARKET ENVIRONMENT

Macroeconomic Indicators

Resident Population by Age Group

Health Insurance Coverage of the US Population, 2004-2014

Acute Conditions by Type

Chronic Conditions by Type

National Health Expenditures by Spending Category

National Health Expenditures by Funding Source

Medical Providers by Type

Patient Activity by Type

Pharmaceutical Demand by Therapeutic Class

Pharmaceutical Demand by Dosage Formulation

Pharmaceutical Demand by Regulatory Classification

Pharmaceutical Demand by Patent Status

DRUG DELIVERY PRODUCT OVERVIEW

Drug Delivery Product Demand by Type

Drug Delivery Product Demand Patterns, 2004-2014

US Trade in Drug Delivery Products

World Drug Delivery Product Demand by Region

ORAL DRUG DELIVERY PRODUCTS

Oral Drug Delivery Product Demand by Type

Controlled-Release Oral Drug Delivery Product Demand

Film-Coated Oral Drug Delivery Product Demand

Diffusion Oral Drug Delivery Product Demand

Reservoir Oral Drug Delivery Product Demand

Chewable Tablet Product Demand by Therapeutic Class

Orally Disintegrating Tablet Demand by Therapeutic Class

Oral Nanoparticulate Drug Delivery Product Demand by Therapeutic Class

Transmucosal Drug Delivery Product Demand by Therapeutic Class

PARENTERAL DRUG DELIVERY PRODUCTS

Parenteral Drug Delivery Product Demand by Type

Therapeutic Monoclonal Antibody Demand by Therapeutic Class

Encapsulated Parenteral Product Demand by Typ & Therapeutic Class

Infusion Product Demand by Type

Parenteral Device Demand by Type

OTHER DRUG DELIVERY PRODUCTS

Other Drug Delivery Product Demand by Type

Inhalation Drug Delivery Product Demand by Type

Dry Powder Inhaler Demand

Metered Dose Inhaler Demand

Transdermal Drug Delivery Product Demand by Therapeutic Class

Implantable Drug Delivery Product Demand by Type

Drug Insert Demand by Therapeutic Class

Drug-Eluting Stent Demand

Other Implantable Drug Delivery Product Demand by Type

APPLICATIONS

Drug Delivery Product Demand by Therapeutic Class

Central Nervous System Drug Delivery Product Demand by Type

Hormone & Related Drug Delivery Product Demand by Type

Respiratory Drug Delivery Product Demand by Type

Anti-Infective Drug Delivery Product Demand by Type

Cardiovascular Drug Delivery Product Demand by Type

Gastrointestinal Drug Delivery Product Demand by Type

Nutritional Preparation Delivery Product Demand by Type

Other Application Drug Delivery Product Demand by Type

INDUSTRY STRUCTURE

US Drug Delivery Product Sales by Company, 2014

Selected Acquisitions & Divestitures

Selected Cooperative Agreements

© by The Freedonia Group, Inc.